2012
DOI: 10.1007/s00432-012-1228-9
|View full text |Cite
|
Sign up to set email alerts
|

Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round

Abstract: The indicated performance indicators fit into the range observed in comparable trials. The study continues finalizing the second screening round and for the first participants even the last screening round. The unresolved issue of the precise amount of side effects and the high early recall rate precludes currently the recommendation of MSCT as screening tool for lung cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
98
0
8

Year Published

2013
2013
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 167 publications
(115 citation statements)
references
References 15 publications
8
98
0
8
Order By: Relevance
“…Examples would be non-contrast cardiac CTs in the Heinz-Nixdorf Recall Study, the Rotterdam Study, the AGESReykjavik Study or the Swedish CardioPulmonary BioImage Study for quantifying coronary calcification [22,27,34,35]. Another example would be the use of low-dose CT for lung cancer screening [36,37]. The use of x-rays must always be assessed in relation to the scientific and social benefits, and the implicit risk must be justified.…”
Section: Analysis Of Image-based Features In Association With Clinicamentioning
confidence: 99%
“…Examples would be non-contrast cardiac CTs in the Heinz-Nixdorf Recall Study, the Rotterdam Study, the AGESReykjavik Study or the Swedish CardioPulmonary BioImage Study for quantifying coronary calcification [22,27,34,35]. Another example would be the use of low-dose CT for lung cancer screening [36,37]. The use of x-rays must always be assessed in relation to the scientific and social benefits, and the implicit risk must be justified.…”
Section: Analysis Of Image-based Features In Association With Clinicamentioning
confidence: 99%
“…Three studies did not demonstrate a benefit of lung cancer screening with CT in terms of mortality, but these were insufficiently powered to reliably draw such conclusion [10][11][12] . There are a further five ongoing studies that are yet to report on the final results, but some will be able to give answers to the question whether CT screening improves outcome of lung cancer patients [13][14][15][16][17] . The Nederlands-Leuvens Longkanker Screening Onderzoek (NELSON) study is a Dutch/Belgian project, which recruited 20000 high-risk subjects and randomised half of them for low-dose CT and the other half for CXR screening [13] .…”
Section: Ctmentioning
confidence: 99%
“…Table 1 provides a list of select RCTs and highlights the differences in their respective inclusion criteria, screening intervals and definitions for positive screen results. [25][26][27][28][29][30][31] Since the ultimate objective of screening is to identify and treat early-stage LC, the participants' fitness for lung surgery is an important factor to consider when assessing eligibility for screening. [12] Accordingly, it is noteworthy that all the trials listed excluded those individuals with comorbidities that precluded them from curative LC surgery.…”
Section: Screening With Ldctmentioning
confidence: 99%
“…NLST [16] DANTE [26] DLCST [27] LUSI [28] ITALUNG [29] MILD [30] NELSON [ Table 2. Professional Societies' Guidelines for LC Screening [25] Society (Reference) Recommendation Grade NCCN [19] Annual LDCT in high-risk individuals Group 1: age 55 -79 y with >30 pack-years, current or former smokers who quit within the past 15 y Group 2: age >50 y with >20 pack-years and 1 additional risk factor * B USPSTF [12] Annual LDCT in high-risk individuals: age 55 -80 y with >30 pack-years, current or former smokers who have quit within the past 15 y † B ACCP/ASCO [17] Annual LDCT in high-risk individuals: age 55 -74 y with >30 pack-years, current or former smokers who quit within the past 15 y, but only in settings that can provide multidisciplinary care similar to that provided in the NLST 2B ACS [32] Annual LDCT in high-risk individuals: age 55 -74 y with >30 pack-years, current or former smokers who quit within the past 15 y, who are in good health B AATS [33] Annual Overdiagnosis refers to the detection of a cancer that would not otherwise have become clinically relevant during the patient's lifetime.…”
Section: Reviewmentioning
confidence: 99%